Abstract
The presentation of the Mesothelioma and Radical Surgery 2 trial, a randomized controlled trial comparing pleurectomy/decortication to no surgery, injected new data into the contentious discussion surrounding the use of surgery in the management of diffuse pleural mesothelioma. We review the trial results in the context of the existing work surrounding the use of surgery in pleural mesothelioma.
Original language | English |
---|---|
Journal | Seminars in Thoracic and Cardiovascular Surgery |
DOIs | |
State | Accepted/In press - 2024 |
Keywords
- extrapleural pneumonectomy
- MARS2
- pleural mesothelioma
- pleurectomy/decortication